Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Shares Issued (2016 - 2022)

Vanda Pharmaceuticals (VNDA) has disclosed Shares Issued for 12 consecutive years, with $600000.0 as the latest value for Q4 2022.

  • Quarterly Shares Issued fell 42.86% to $600000.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $600000.0 through Dec 2023, down 14.29% year-over-year, with the annual reading at $700000.0 for FY2022, 80.28% down from the prior year.
  • Shares Issued hit $600000.0 in Q4 2022 for Vanda Pharmaceuticals, up from $100000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $100.9 million in Q1 2018 to a low of -$95.5 million in Q2 2018.
  • Historically, Shares Issued has averaged $6.9 million across 5 years, with a median of $600000.0 in 2022.
  • Biggest YoY gain for Shares Issued was 4467.68% in 2018; the steepest drop was 4454.77% in 2018.
  • Year by year, Shares Issued stood at $95.5 million in 2018, then plummeted by 97.78% to $2.1 million in 2019, then crashed by 32.23% to $1.4 million in 2020, then dropped by 26.78% to $1.0 million in 2021, then plummeted by 42.86% to $600000.0 in 2022.
  • Business Quant data shows Shares Issued for VNDA at $600000.0 in Q4 2022, $100000.0 in Q2 2022, and $1.0 million in Q4 2021.